Genscript Biotech Corporation ( GNNSF) - Stock Earnings

GNNSF Quarterly earnings

DateEarningsRevenue
2024Q2 -175.1 million USD 561.4 million USD
2024Q4 3.1 billion USD 33.1 million USD
2025Q2 -25.5 million USD 518.8 million USD

GNNSF Yearly earnings

DateEarningsRevenue
2022 -226.9 million USD 625.7 million USD
2023 -95.5 million USD 839.5 million USD
2024 3.0 billion USD 594.5 million USD

GNNSF

Price: $1.60

52 week price:
1.30
2.42

Payout Ratio Range:
0.02%
17.58%

Earnings Per Share: -0.25 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.5 billion

Links: